share_log

Wells Fargo Maintains Overweight on Bio-Rad Laboratories, Lowers Price Target to $525

Benzinga ·  Aug 7, 2023 08:05

Wells Fargo analyst Dan Leonard maintains Bio-Rad Laboratories (NYSE:BIO) with a Overweight and lowers the price target from $550 to $525.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment